NMPA Approval

Bevacizumab Injection

Approval Number

国药准字S20210049

Company东曜药业有限公司

Registration Date

November 30, 2021

Drug Information

Generic Name

贝伐珠单抗注射液

Trade Name

朴欣汀

Dosage Form

注射剂

Strength

100mg(4ml)/瓶

Drug Type

生物制品

Registration Date

November 30, 2021

Company Information

Applicant Company

Company Name东曜药业有限公司

Company Address

苏州工业园区长阳街120号

Manufacturing Company

Company Name东曜药业有限公司

Company Address

苏州工业园区长阳街120号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

贝伐珠单抗注射液 - NMPA 批准文号 | MedPath